HilleVax, Inc.
HLVX
$1.86
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.55% | -4.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -33.18% | -56.87% | |||
| Operating Income | 33.18% | 56.87% | |||
| Income Before Tax | 82.15% | -31.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 82.15% | -31.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 82.15% | -31.46% | |||
| EBIT | 33.18% | 56.87% | |||
| EBITDA | 32.55% | 57.91% | |||
| EPS Basic | 91.14% | -161.85% | |||
| Normalized Basic EPS | 54.24% | 42.63% | |||
| EPS Diluted | 91.17% | -162.59% | |||
| Normalized Diluted EPS | 54.24% | 42.63% | |||
| Average Basic Shares Outstanding | 0.80% | 0.41% | |||
| Average Diluted Shares Outstanding | 0.80% | 0.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||